Not applicableStudy completedNCT01365962What this trial is testingBiomarker in Tumor Tissue Samples From Patients With RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 60
Not applicableStudy completedNCT01426945What this trial is testingProtein Expression in Samples From Young Patients With RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 77
Not applicableStudy completedNCT01668095What this trial is testingBiomarkers in Patients With Advanced RhabdomyosarcomaWho this might be right forAdult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+5 more Children's Oncology Group 10
Large-scale testing (Phase 3)UnknownNCT00379457What this trial is testingCombination Chemotherapy in Treating Young Patients With Nonmetastatic RhabdomyosarcomaWho this might be right forSarcoma European Paediatric Soft Tissue Sarcoma Study Group 600
Large-scale testing (Phase 3)Study completedNCT00354835What this trial is testingCombination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaWho this might be right forAdult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Botryoid-Type Embryonal Rhabdomyosarcoma+7 more Children's Oncology Group 481
Testing effectiveness (Phase 2)Study completedNCT01614795What this trial is testingCixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory SarcomaWho this might be right forChildhood Alveolar Soft Part SarcomaChildhood AngiosarcomaChildhood Epithelioid Sarcoma+12 more National Cancer Institute (NCI) 46
Large-scale testing (Phase 3)Ended earlyNCT01132547What this trial is testingCyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerWho this might be right forCancer University of South Florida 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT00077285What this trial is testingIrinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk RhabdomyosarcomaWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 65
Not applicableWithdrawnNCT00334984What this trial is testingGlutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma Children's Oncology Group
Very early researchStudy completedNCT00662233What this trial is testingCombination Chemotherapy in Treating Patients With SarcomaWho this might be right forOvarian CancerSarcoma Mayo Clinic 28
Testing effectiveness (Phase 2)Study completedNCT00002515What this trial is testingCombination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerWho this might be right forChildhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01567046What this trial is testingStudying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasWho this might be right forChildhood Alveolar Soft-part SarcomaChildhood AngiosarcomaChildhood Desmoplastic Small Round Cell Tumor+12 more Children's Oncology Group 70
Testing effectiveness (Phase 2)Study completedNCT01222715What this trial is testingVinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory RhabdomyosarcomaWho this might be right forAdult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Pleomorphic Rhabdomyosarcoma+4 more National Cancer Institute (NCI) 87
Not applicableStudy completedNCT01433237What this trial is testingStudying Biomarkers in Samples From Patients With RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 40
Testing effectiveness (Phase 2)Study completedNCT00003955What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaWho this might be right forSarcoma Children's Oncology Group 77
Testing effectiveness (Phase 2)Study completedNCT01055314What this trial is testingTemozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic RhabdomyosarcomaWho this might be right forAdult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+3 more National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00003745What this trial is testingChemotherapy in Treating Children With Recurrent or Refractory SarcomasWho this might be right forSarcoma National Cancer Institute (NCI) 125
Not applicableStudy completedNCT06040229What this trial is testingRetrospective Study in FFPE Samples From Younger Patients With RhabdomyosarcomaWho this might be right forAlveolar Childhood RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaRecurrent Childhood Rhabdomyosarcoma Shandong First Medical University 6
Testing effectiveness (Phase 2)Study completedNCT00031915What this trial is testingImatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00025363What this trial is testingComparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaWho this might be right forAlveolar Childhood RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood Rhabdomyosarcoma+2 more National Cancer Institute (NCI) 150